Simtra BioPharma Solutions U.S. Manufacturing Expansion

planned

Simtra BioPharma Solutions purchased a 65-acre property with over 300,000 square feet of space near its existing manufacturing facility in Bloomington, Indiana, to expand its U.S. manufacturing capacity for injectable medicines, including commercial-scale production of oncology-focused injectable drug products such as antibody-drug conjugates (ADCs). The project includes designing and installing manufacturing lines with isolator-based vial and prefilled syringe filling lines, supporting build-to-suit solutions for customers.